Prader-Willi Syndrome (PWS) Global Clinical Trials Review, H1, 2018

  • ID: 4601580
  • Clinical Trials
  • Region: Global
  • 59 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Corporacion Parc Tauli
  • Eli Lilly and Co
  • Ferring Holding SA
  • Insys Therapeutics Inc
  • Novartis AG
  • Novo A/S
  • MORE
Prader-Willi Syndrome (PWS) Global Clinical Trials Review, H1, 2018

Summary

The author's clinical trial report, “Prader-Willi Syndrome (PWS) Global Clinical Trials Review, H1, 2018" provides an overview of Prader-Willi Syndrome (PWS) clinical trials scenario. This report provides top line data relating to the clinical trials on Prader-Willi Syndrome (PWS). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using the author’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope
  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months
Reasons to buy
  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Corporacion Parc Tauli
  • Eli Lilly and Co
  • Ferring Holding SA
  • Insys Therapeutics Inc
  • Novartis AG
  • Novo A/S
  • MORE
  • Report Guidance
  • Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Top Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Clinical Trials by G7 Countries: Proportion of Prader-Willi Syndrome (PWS) to Genetic Disorders Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Prader-Willi Syndrome (PWS) to Genetic Disorders Clinical Trials
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Prader-Willi Syndrome (PWS)
  • May 29, 2018: Saniona reports positive results from Phase 1 study with new Tesomet tablet
  • May 14, 2018: Soleno Therapeutics Announces Initiation of Phase III Clinical Trial of DCCR in Prader-Willi Syndrome
  • Apr 27, 2018: INSYS Therapeutics Initiates Phase 2 Clinical Trial of Cannabidiol (CBD) for Treatment of Prader-Willi Syndrome
  • Apr 26, 2018: Saniona progress to second part of Phase 2a study for Tesomet in Prader-Willi Syndrome based on positive results in adult patients
  • Clinical Trial Profile Snapshots
  • Appendix
  • Abbreviations
  • Definitions
  • Research Methodology
  • Secondary Research
  • About
  • Contact
  • Source
List of Tables
  • Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials by Region, 2018*
  • Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018*
  • Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018*
  • Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2018*
  • Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Europe, Top Five Countries, 2018*
  • Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, North America, Top Countries, 2018*
  • Proportion of Prader-Willi Syndrome (PWS) to Genetic Disorders Clinical Trials, G7 Countries (%), 2018*
  • Prader-Willi Syndrome (PWS) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018*
  • Prader-Willi Syndrome (PWS) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018*
  • Proportion of Prader-Willi Syndrome (PWS) to Genetic Disorders Clinical Trials, E7 Countries (%), 2018*
  • Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials by Phase, 2018*
  • Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials In Progress by Phase 2018*
  • Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials by Trial Status, 2018*
  • Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, by End Point Status, 2018*
  • Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017
  • Prader-Willi Syndrome (PWS) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018*
  • Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, Key Sponsors, 2018*
  • Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018*
  • Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018*
List of Figures
  • Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials by Region (%), 2018*
  • Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018*
  • Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018*
  • Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2018*
  • Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018*
  • Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, North America, Top Countries (%), 2018*
  • Proportion of Prader-Willi Syndrome (PWS) to Genetic Disorders Clinical Trials, G7 Countries (%), 2018*
  • Prader-Willi Syndrome (PWS) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018*
  • Prader-Willi Syndrome (PWS) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018*
  • Proportion of Prader-Willi Syndrome (PWS) to Genetic Disorders Clinical Trials, E7 Countries (%), 2018*
  • Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials by Phase (%), 2018*
  • Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials In Progress by Phase, 2018*
  • Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials by Trial Status, 2018*
  • Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, by End Point Status, 2018*
  • Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017
  • Prader-Willi Syndrome (PWS) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018*
  • Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, Key Sponsors, 2018*
  • Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018*
  • Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018*
  • Methodology
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Novo A/S
  • Zafgen Inc
  • Soleno Therapeutics Inc
  • Chong Kun Dang Pharmaceutical Corp
  • Pfizer Inc
  • Novartis AG
  • Insys Therapeutics Inc
  • Ferring Holding SA
  • Eli Lilly and Co
  • Corporacion Parc Tauli
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll